Experimental Sepsis Models: Advantages and Limitations

Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclin...

Full description

Saved in:
Bibliographic Details
Published inThe Eurasian journal of medicine Vol. 55; no. 1; pp. 120 - S124
Main Authors Aydın, Pelin, Bekmez, Hüseyin
Format Journal Article
LanguageEnglish
Published Turkey AVES 01.12.2023
Atatürk University School of Medicine
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models.
AbstractList Sepsis is a major health problem that causes millions of deaths worldwide every year: Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year: Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has different strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on different models.
Sepsis is a major health problem that causes millions of deaths worldwide every year: Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year: Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has different strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on different models. Keywords: Sepsis, experimental model, CLP LPS
Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models.
Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models.Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models.
Audience Academic
Author Bekmez, Hüseyin
Aydın, Pelin
Author_xml – sequence: 1
  givenname: Pelin
  surname: Aydın
  fullname: Aydın, Pelin
  organization: Department of Pharmacology, Atatürk University Faculty of Medicine, Erzurum, Turkey
– sequence: 2
  givenname: Hüseyin
  surname: Bekmez
  fullname: Bekmez, Hüseyin
  organization: Department of Anesthesiology and Reanimation, Erzurum City Hospital, Erzurum, Turkey
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39109920$$D View this record in MEDLINE/PubMed
BookMark eNptkU1PAjEQhhuDEUT-gm7ixQvYdna7Wy-GEPxIMB7Uc1O6s1iy28XtQvTfWwMSSWwP08w8fftO55R0XO2QkAtGRwlL-DWuG-2tdssK8xGnHEYcQMRHpMeAZsMsjXlnf4a4SwbeL2lYsQTg4oR0QTIqJac9IqafK2xsha7VZfSCK2999FTnWPqbaJxvdMgv0Efa5dHMVrbVra2dPyPHhS49DnaxT97upq-Th-Hs-f5xMp4NTQysHWbIBfA5JDwrRGIKk1Im5VzKUA6RzRmyxIg0zxjGoBkA0yyPBS806FQa6JPbre5qPQ_dmmCz0aVaBce6-VK1tuqw4uy7WtQbxRhNE8qSoHC1U2jqjzX6VlXWGyxL7bBeexV-SWZZeDkN6OUWXegSlXVFHSTND67GaSaogCSNAzX6hwo7x8qaMKnChvzBhfO_PezN_w4BvgFqkY1f
ContentType Journal Article
Copyright COPYRIGHT 2023 AVES
2024 authors 2024 authors
Copyright_xml – notice: COPYRIGHT 2023 AVES
– notice: 2024 authors 2024 authors
DBID NPM
7X8
5PM
DOI 10.5152/eurasianjmed.2023.23364
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1308-8742
EndPage S124
ExternalDocumentID A786063574
39109920
Genre Journal Article
GeographicLocations Turkey
GeographicLocations_xml – name: Turkey
GroupedDBID 3V.
53G
7RQ
7X7
8FI
8R4
8R5
AAWTL
ABDBF
ADBBV
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
BPHCQ
BVXVI
DIK
EDSIH
EOJEC
ESX
FYUFA
GROUPED_DOAJ
HYE
IAO
IHR
INH
INR
ITC
MK0
NPM
OBODZ
PIMPY
PQQKQ
PROAC
Q2X
RNS
RPM
TUS
7X8
5PM
ID FETCH-LOGICAL-c431t-8e2632b3528f65cfc70199b99c4399b1b1e15c67d81e43a1331a1d462fa3a79c3
IEDL.DBID RPM
ISSN 1308-8734
IngestDate Tue Sep 17 21:29:25 EDT 2024
Sat Oct 26 04:26:40 EDT 2024
Wed Mar 27 18:02:05 EDT 2024
Tue Mar 26 04:58:51 EDT 2024
Tue Oct 29 09:18:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c431t-8e2632b3528f65cfc70199b99c4399b1b1e15c67d81e43a1331a1d462fa3a79c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Cite this article as: Aydın P, Bekmez H. Experimental sepsis models: Advantages and limitations. Eurasian J Med., 2023;55(Suppl. Issue: 1):S120-S124.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075015/
PMID 39109920
PQID 3089881337
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11075015
proquest_miscellaneous_3089881337
gale_infotracmisc_A786063574
gale_infotracacademiconefile_A786063574
pubmed_primary_39109920
PublicationCentury 2000
PublicationDate 2023-12-01
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Turkey
PublicationPlace_xml – name: Turkey
PublicationTitle The Eurasian journal of medicine
PublicationTitleAlternate Eurasian J Med
PublicationYear 2023
Publisher AVES
Atatürk University School of Medicine
Publisher_xml – name: AVES
– name: Atatürk University School of Medicine
SSID ssj0000493326
Score 2.305062
Snippet Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment...
Sepsis is a major health problem that causes millions of deaths worldwide every year: Due to the complexity of its pathophysiology, there is no clear treatment...
SourceID pubmedcentral
proquest
gale
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 120
SubjectTerms Anesthesiology and Reanimation
Biological models
Methods
Review
Sepsis
Title Experimental Sepsis Models: Advantages and Limitations
URI https://www.ncbi.nlm.nih.gov/pubmed/39109920
https://www.proquest.com/docview/3089881337
https://pubmed.ncbi.nlm.nih.gov/PMC11075015
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fS8MwED7UB_FF_O38RQXBp25Lk6aJbyIbIkwEFXwrSZrixNVht__fu3ST1Uefk0B6_Zq7a777DuBKlKqvCpXGpZZlLHiSxtZKHfedTAx6XOUZFTiPHuX9q3h4S9_WQC5rYQJp39lxt_qcdKvxe-BWTieut-SJ9Z5Gd5SzpOjHeuuwjghdydE_mpiX89BnDc9nhZ87Fw2xC1130vPz71Ce-IHOpku9w7sJ56Q38PdEXnFJbbrkiv8Z7sD2InCMbpsN7sKar_Zgc7S4Gt8HOVjR6o-e_bQe1xF1Ovusb6LQO3mGR0cdmaqIQlVT86vuAF6Hg5e7-3jRFCF26OtnsfKksG5JlKWUqSsd6alrq7WjzMIyyzxLncwKxbzgBlNQZlghZFIabjLt-CFsVF-VP4bIC6eZ8NyUWSKs8MZmQlqTGo9RQcFcB67JJjlBHR_cmQVjH1eTaFR-mylMf3iaiQ6ctWYiRF1r-HJp1ZyGiNdV-a95neML0krhJrMOHDVWzqeNzEbONd3aJf0OqJb9fyeQMnZ7BAETFLKXADn5_9JT2CJ0NMyVM9iYfc_9OcYfM3sR8vaLALoftMvbpg
link.rule.ids 230,315,730,783,787,867,888,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB1RKrVcaGkLLOUjlSr1lOw6dhybG0KgpWVRpYLKLbIdR10KYUWyF349M8mm2nAr57ElxzP2zMRv3gB8FYUaqVwlYaFlEQoeJ6G1UocjJ2ODHld5RgXOkws5vhLfr5PrFZBdLUwD2nd2GpW3d1E5_dNgK2d3btjhxIY_J8eUsyTox4av4DUe2JFcytJv2qiX86bTGt7QCg88Fy20C513PPTzh6ZA8QbdTUTdw6OYc2IceH4nLzmlPmByyQOdvoPf3dpb4MnfaF7byD0-o3X8_497D-uLoDQ4auUbsOLLD_Bmsnh2_wjyZKkPQPDLz6ppFVAXtdvqMGj6Mtd4LVWBKfOgqZhqfwN-gqvTk8vjcbhouBA6jCPqUHlib7dE-FLIxBWOuNq11dpR1mKZZZ4lTqa5Yl5wg-ktMywXMi4MN6l2fBNWy_vSb0PghdNMeG6KNBZWeGNTIa1JjMeII2duAN9otzM6RrilziyqAXA2EVJlR6nC1IonqRjAbm8kmr_rib90-spIRJix0t_PqwxVr5XCRaYD2Gr1l81aCo-Ma3oRjEcDUD3N_htArNt9CeqrYd_u9LPz8qkH8HZ8OTnPzs8ufnyGNbLBFiGzC6v1w9zvYZxT2_3GqJ8Ag7T8zg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BlRCXlr7otkBTqVJPSdax49jcELCCtouQWiSkHiLbccRSCCuSvfTXdybJog1HzrYlx-N5xd98A_BVlGqsCpWGpZZlKHiShtZKHY6dTAx6XOUZFThPz-Xppfh-lV71qMq6h1VWzs6i6vYuqmbXLbZyfufiJU4svpgeUc6Soh-L50UZr8MLVNqxWsnUb7rIl_O22xpaaYVKz0UH70IHnsR-8dAWKd6gy4mog3iUcE6sA0_t8opjGoImV7zQ5BX8We6_A5_8jRaNjdy_J9SOz_vAbXjZB6fBYTfnNaz56g1sTvvn97cgT1b6AQS__Lye1QF1U7utD4K2P3OD5qkOTFUEbeVU9zvwHVxOTn4fnYZ944XQYTzRhMoTi7sl4pdSpq50xNmurdaOshfLLPMsdTIrFPOCG0xzmWGFkElpuMm04-9ho7qv_AcIvHCaCc9NmSXCCm9sJqQ1qfEYeRTMjeAbnXhO6oTH6kxfFYCriZgqP8wUplg8zcQIdgczUQ3cYPjLUmY5DRF2rPL3izpH8WulcJPZCHY6Gebzjsoj55peBpPxCNRAuo8TiH17OIIya1m4lzL6-Pyln2Hz4niS_zw7__EJtugadkCZXdhoHhZ-D8Odxu639_o_fID_Tg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Experimental+Sepsis+Models%3A+Advantages+and+Limitations&rft.jtitle=The+Eurasian+journal+of+medicine&rft.au=Ayd%C4%B1n%2C+Pelin&rft.au=Bekmez%2C+H%C3%BCseyin&rft.date=2023-12-01&rft.issn=1308-8734&rft.volume=55&rft.issue=1&rft.spage=120&rft_id=info:doi/10.5152%2Feurasianjmed.2023.23364&rft_id=info%3Apmid%2F39109920&rft.externalDocID=39109920
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1308-8734&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1308-8734&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1308-8734&client=summon